Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RA Capital
Pharma
Contraline gins up $92.5M in male birth control development push
Contraline is developing what could be a first-in-class male birth control that has garnered enthusiasm from a host of big-name investors.
Fraiser Kansteiner
Jun 2, 2026 8:00am
Fierce Biotech
Ramaswamy-backed Ambros launches with $125M to develop pain med
Dec 16, 2025 1:32pm
Sublingual psychedelic startup nets $60M for depression trials
Nov 8, 2022 7:30am
Getting Cerebral: VCs bet $40M on epilepsy implant development
Jul 5, 2022 8:55am
